107 related articles for article (PubMed ID: 21653685)
1. Enhanced antitumor effects by chemical modified IGb3 analogues.
Zhou Z; Zhang C; Xia C; Chen W; Zhu H; Shang P; Ma F; Wang PG; Zhang J; Xu W; Tian Z
Mol Cancer Ther; 2011 Aug; 10(8):1375-84. PubMed ID: 21653685
[TBL] [Abstract][Full Text] [Related]
2. Chemical modification of iGb3 increases IFN-gamma production by hepatic NKT cells.
Shang P; Zhang C; Xia C; Chen W; Han Q; Wang PG; Zhang J; Tian Z
Int Immunopharmacol; 2008 May; 8(5):645-53. PubMed ID: 18387506
[TBL] [Abstract][Full Text] [Related]
3. Modification of the ceramide moiety of isoglobotrihexosylceramide on its agonist activity in stimulation of invariant natural killer T cells.
Xia C; Schümann J; Emmanuel R; Zhang Y; Chen W; Zhang W; De Libero G; Wang PG
J Med Chem; 2007 Jul; 50(15):3489-96. PubMed ID: 17608465
[TBL] [Abstract][Full Text] [Related]
4. Alpha anomers of iGb3 and Gb3 stimulate cytokine production by natural killer T cells.
Yin N; Long X; Goff RD; Zhou D; Cantu C; Mattner J; Mezard PS; Teyton L; Bendelac A; Savage PB
ACS Chem Biol; 2009 Mar; 4(3):199-208. PubMed ID: 19175331
[TBL] [Abstract][Full Text] [Related]
5. Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors.
Pellicci DG; Clarke AJ; Patel O; Mallevaey T; Beddoe T; Le Nours J; Uldrich AP; McCluskey J; Besra GS; Porcelli SA; Gapin L; Godfrey DI; Rossjohn J
Nat Immunol; 2011 Jul; 12(9):827-33. PubMed ID: 21804559
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues.
Chen W; Xia C; Wang J; Thapa P; Li Y; Talukdar A; Nadas J; Zhang W; Zhou D; Wang PG
J Org Chem; 2007 Dec; 72(26):9914-23. PubMed ID: 18020363
[TBL] [Abstract][Full Text] [Related]
7. CD1d protein structure determines species-selective antigenicity of isoglobotrihexosylceramide (iGb3) to invariant NKT cells.
Sanderson JP; Brennan PJ; Mansour S; Matulis G; Patel O; Lissin N; Godfrey DI; Kawahara K; Zähringer U; Rossjohn J; Brenner MB; Gadola SD
Eur J Immunol; 2013 Mar; 43(3):815-25. PubMed ID: 23280365
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of mouse CD1d-iGb3 complex and its cognate Valpha14 T cell receptor suggest a model for dual recognition of foreign and self glycolipids.
Zajonc DM; Savage PB; Bendelac A; Wilson IA; Teyton L
J Mol Biol; 2008 Apr; 377(4):1104-16. PubMed ID: 18295796
[TBL] [Abstract][Full Text] [Related]
9. Thio-isoglobotrihexosylceramide, an agonist for activating invariant natural killer T cells.
Xia C; Zhou D; Liu C; Lou Y; Yao Q; Zhang W; Wang PG
Org Lett; 2006 Nov; 8(24):5493-6. PubMed ID: 17107055
[TBL] [Abstract][Full Text] [Related]
10. Glycolipid iGb3 feedback amplifies innate immune responses via CD1d reverse signaling.
Liu X; Zhang P; Zhang Y; Wang Z; Xu S; Li Y; Huai W; Zhou Q; Chen X; Chen X; Li N; Wang P; Li Y; Cao X
Cell Res; 2019 Jan; 29(1):42-53. PubMed ID: 30514903
[TBL] [Abstract][Full Text] [Related]
11. A divergent approach to the synthesis of iGb3 sugar and lipid analogues via a lactosyl 2-azido-sphingosine intermediate.
Cheng JM; Dangerfield EM; Timmer MS; Stocker BL
Org Biomol Chem; 2014 May; 12(17):2729-36. PubMed ID: 24652424
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal glycosphingolipid recognition by NKT cells.
Zhou D; Mattner J; Cantu C; Schrantz N; Yin N; Gao Y; Sagiv Y; Hudspeth K; Wu YP; Yamashita T; Teneberg S; Wang D; Proia RL; Levery SB; Savage PB; Teyton L; Bendelac A
Science; 2004 Dec; 306(5702):1786-9. PubMed ID: 15539565
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: structural basis for the recognition of β-linked glycolipid antigens by invariant NKT cells.
Yu ED; Girardi E; Wang J; Zajonc DM
J Immunol; 2011 Sep; 187(5):2079-83. PubMed ID: 21810611
[TBL] [Abstract][Full Text] [Related]
14. Identification of iGb3 and iGb4 in melanoma B16F10-Nex2 cells and the iNKT cell-mediated antitumor effect of dendritic cells primed with iGb3.
Dias BR; Rodrigues EG; Nimrichter L; Nakayasu ES; Almeida IC; Travassos LR
Mol Cancer; 2009 Dec; 8():116. PubMed ID: 19968878
[TBL] [Abstract][Full Text] [Related]
15. Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells.
Porubsky S; Speak AO; Salio M; Jennemann R; Bonrouhi M; Zafarulla R; Singh Y; Dyson J; Luckow B; Lehuen A; Malle E; Müthing J; Platt FM; Cerundolo V; Gröne HJ
J Immunol; 2012 Sep; 189(6):3007-17. PubMed ID: 22875802
[TBL] [Abstract][Full Text] [Related]
16. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency.
Porubsky S; Speak AO; Luckow B; Cerundolo V; Platt FM; Gröne HJ
Proc Natl Acad Sci U S A; 2007 Apr; 104(14):5977-82. PubMed ID: 17372206
[TBL] [Abstract][Full Text] [Related]
17. Regulation by Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 of alpha-galactosylceramide-induced antimetastatic activity and Th1 and Th2 responses of NKT cells.
Okajo J; Kaneko Y; Murata Y; Tomizawa T; Okuzawa C; Saito Y; Kaneko Y; Ishikawa-Sekigami T; Okazawa H; Ohnishi H; Matozaki T; Nojima Y
J Immunol; 2007 May; 178(10):6164-72. PubMed ID: 17475843
[TBL] [Abstract][Full Text] [Related]
18. Efficient activation of Valpha14 invariant NKT cells by foreign lipid antigen is associated with concurrent dendritic cell-specific self recognition.
Cheng L; Ueno A; Cho S; Im JS; Golby S; Hou S; Porcelli SA; Yang Y
J Immunol; 2007 Mar; 178(5):2755-62. PubMed ID: 17312118
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.
Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L
J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646
[TBL] [Abstract][Full Text] [Related]
20. Interdependency of MHC class II/self-peptide and CD1d/self-glycolipid presentation by TNF-matured dendritic cells for protection from autoimmunity.
Wiethe C; Schiemann M; Busch D; Haeberle L; Kopf M; Schuler G; Lutz MB
J Immunol; 2007 Apr; 178(8):4908-16. PubMed ID: 17404272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]